- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Avenue Therapeutics (NASDAQ:ATXI), Quotes and News Summary
Avenue Therapeutics (NASDAQ: ATXI)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-23 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.140 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Avenue Therapeutics Questions & Answers
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
Other companies in Avenue Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by HC Wainwright & Co. on Tuesday, May 12, 2020. The analyst firm set a price target for 13.00 expecting ATXI to rise to within 12 months (a possible 4415.46% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $0.2879 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Avenue Therapeutics.
Avenue Therapeutics’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Avenue Therapeutics.
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.